Maintaining iron balance in women blood donors of childbearing age: summary of a workshop
2002; Wiley; Volume: 42; Issue: 6 Linguagem: Inglês
10.1046/j.1537-2995.2002.00103.x
ISSN1537-2995
AutoresCelso Bianco, Gary M. Brittenham, Ronald O. Gilcher, Victor R. Gordeuk, James P. Kushner, Merlyn Sayers, Linda A. Chambers, Richard B. Counts, Cheryl Aylesworth, George J. Nemo, Barbara M. Alving,
Tópico(s)Blood donation and transfusion practices
ResumoTransfusionVolume 42, Issue 6 p. 798-805 Maintaining iron balance in women blood donors of childbearing age: summary of a workshop Celso Bianco, Celso Bianco From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorGary Brittenham, Gary Brittenham From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorRonald O. Gilcher, Ronald O. Gilcher From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorVictor R. Gordeuk, Victor R. Gordeuk From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorJames P. Kushner, James P. Kushner From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorMerlyn Sayers, Merlyn Sayers From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorLinda Chambers, Linda Chambers From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorRichard B. Counts, Richard B. Counts From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorCheryl Aylesworth, Cheryl Aylesworth From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorGeorge Nemo, George Nemo From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorBarbara Alving, Barbara Alving From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this author Celso Bianco, Celso Bianco From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorGary Brittenham, Gary Brittenham From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorRonald O. Gilcher, Ronald O. Gilcher From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorVictor R. Gordeuk, Victor R. Gordeuk From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorJames P. Kushner, James P. Kushner From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorMerlyn Sayers, Merlyn Sayers From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorLinda Chambers, Linda Chambers From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorRichard B. Counts, Richard B. Counts From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorCheryl Aylesworth, Cheryl Aylesworth From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorGeorge Nemo, George Nemo From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this authorBarbara Alving, Barbara Alving From the America's Blood Centers, Washington, DC; Columbia University, New York, New York; Oklahoma Blood Institute, Oklahoma City, Oklahoma; Center for Sickle Cell Disease, Howard University, Washington, DC; Division of Hematology, University of Utah Medical Center, Salt Lake City, Utah; Carter Blood Care, Bedford, Texas; American Red Cross, Arlington, Virginia; Puget Sound Blood Center, Seattle, Washington; Uniformed Services University of the Health Sciences, Bethesda, Maryland; National Heart, Lung, and Blood Institute, NIH, Bethesda, MarylandSearch for more papers by this author First published: 03 July 2002 https://doi.org/10.1046/j.1537-2995.2002.00103.xCitations: 63 Address reprint requests to: Barbara Alving, MD, National Heart, Lung, and Blood Institute, Building 31, Room 5A47, 31 Center Drive, MSC 2490, Bethesda, MD 20892-2490; e-mail: alvingb@nih.gov . ABBREVIATION: HFE = HLA-linked hemochromatosis gene. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume42, Issue6June 2002Pages 798-805 RelatedInformation
Referência(s)